Risk factors for persistent hyperparathyroidism in children with stable renal function after kidney transplantation

被引:7
作者
Kim, Da Hyun [1 ]
Lee, Joo Hoon [1 ]
Han, Duck Jong [2 ]
Park, Young Seo [1 ]
机构
[1] Univ Ulsan, Coll Med, Dept Pediat, Asan Med Ctr,Childrens Hosp, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Dept Surg, Asan Med Ctr, Seoul, South Korea
关键词
children; hyperparathyroidism; kidney transplantation; SECONDARY HYPERPARATHYROIDISM; METABOLISM; DISEASE; BONE; HYPERCALCEMIA; CINACALCET;
D O I
10.1111/petr.13238
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This study aimed to investigate the risk factors for PHPT in children with stable renal function who received KT. We retrospectively analyzed the clinical findings and laboratory results of patients who underwent KT below 19years of age, between 1996 and 2016 at our hospital. Patients were followed up for more than 1year after KT. We calculated the mean +/- standard deviation or median [minimum - maximum] for each parameter. We included a total of 46 patients (male:female=26:20). Twelve patients (26.1%) were included in the PHPT group, and 34 (73.9%) were in the nPTH group. The dialysis duration was 57.1 +/- 49.9, 44 [0-145]months in the PHPT group and 23.5 +/- 25.8, 15 [1-121]months in the nPTH group (P=.040). The post-KT total CO2 level was significantly higher in the PHPT group (P=.022). The pre- (P=.021) and post-KT (P=.005) and 3-month average (P=.018) iPTH levels were also significantly higher in PHPT group. The height z-score showed a negative correlation, and the pre-KT, 3-month average phosphorus and alkaline phosphate levels showed positive correlations with iPTH levels, at 1year after KT. Patients who undergo prolonged durations of dialysis, have increased iPTH levels before and after KT, and have low bicarbonate levels after KT are at risk of PHPT and should be monitored carefully.
引用
收藏
页数:7
相关论文
共 18 条
[1]   Reduced parathyroid functional mass after successful kidney transplantation [J].
Bonarek, H ;
Merville, P ;
Bonarek, M ;
Moreau, K ;
Morel, D ;
Aparicio, M ;
Potaux, L .
KIDNEY INTERNATIONAL, 1999, 56 (02) :642-649
[2]   The Phosphate Binder Equivalent Dose [J].
Daugirdas, John T. ;
Finn, William F. ;
Emmett, Michael ;
Chertow, Glenn M. .
SEMINARS IN DIALYSIS, 2011, 24 (01) :41-49
[3]   Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study [J].
Evenepoel, P ;
Claes, K ;
Kuypers, D ;
Maes, B ;
Bammens, B ;
Vanrenterghem, Y .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) :1281-1287
[4]  
Grzela T, 2006, INT J MOL MED, V17, P779
[5]   Low-Grade Persistent Hyperparathyroidism After Pediatric Renal Transplant [J].
Gulleroglu, Kaan ;
Baskin, Esra ;
Moray, Gokhan ;
Haberal, Mehmet .
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 (03) :294-298
[6]   Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism [J].
Indridason, OS ;
Heath, H ;
Khosla, S ;
Yohay, DA ;
Quarles, LD .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1663-1671
[7]  
Jahromi AH, 2009, SAUDI J KIDNEY DIS T, V20, P573
[8]   Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters [J].
Ketteler, Markus ;
Block, Geoffrey A. ;
Evenepoel, Pieter ;
Fukagawa, Masafumi ;
Herzog, Charles A. ;
McCann, Linda ;
Moe, Sharon M. ;
Shroff, Rukshana ;
Tonelli, Marcello A. ;
Toussaint, Nigel D. ;
Vervloet, Marc G. ;
Leonard, Mary B. .
KIDNEY INTERNATIONAL, 2017, 92 (01) :26-36
[9]   K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Children with Chronic Kidney Disease - Foreword [J].
Langman, CB ;
Salusky, IB .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (04) :S6-S121
[10]   Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet [J].
Leca, N. ;
Laftavi, M. ;
Gundroo, A. ;
Kohli, R. ;
Min, I. ;
Karam, J. ;
Sridhar, N. ;
Blessios, G. ;
Venuto, R. ;
Pankewycz, O. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (10) :2391-2395